333D Limited (T3D) AI Stock Analysis

• Market Cap: AU$1.06M
• Dividend Yield: N/A
• Average Volume (3M): 122.26K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.78
• Revenue Growth: 1110.63%
• EPS Growth: 30.61%
• Country: AU
• Employees: N/A
• Sector: Technology
• Sector Strength: 88
• Industry: Computer Hardware
• EPS (TTM): >-0.01
• Shares Outstanding: 176,183,470
• 10 Day Avg. Volume: 49,585
• 30 Day Avg. Volume: 122,260
• PEG Ratio: 0.08
• Price to Book (P/B): -7.52
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -8.93
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 28 Underperform
• Price Target: ―

The most significant factor impacting 333D Limited's stock score is its poor financial performance, characterized by negative profitability, a weak balance sheet, and inadequate cash flow. The lack of technical analysis data and negative valuation metrics further highlight the company's financial distress. Without earnings call or corporate events data to provide additional context or potential positive outlooks, the overall score remains low.

333D Limited Business Overview & Revenue Model

Company Description

333D Limited (T3D) is an Australian-based company specializing in 3D printing technologies and services. The company operates within the technology and manufacturing sectors, providing innovative 3D printing solutions to a diverse clientele, including industries such as education, architecture, and consumer products. 333D Limited focuses on delivering high-quality 3D printed products and services, leveraging advanced technology to meet the demands of its customers.

How the Company Makes Money

333D Limited generates revenue primarily through the sale of 3D printed products and services. The company offers customized 3D printing solutions to various sectors, enabling clients to create prototypes, models, and finished goods. Additionally, 333D Limited may engage in partnerships with other businesses to expand its market reach and enhance its product offerings. The company could also explore opportunities in licensing its technology or collaborating on research and development initiatives to further drive its revenue streams. However, specific details about significant partnerships or additional revenue factors are currently unavailable.

333D Limited Financial Statement Overview

Summary

333D Limited is facing substantial financial challenges. Despite some revenue growth, the company struggles with profitability and has a weak balance sheet. The high level of liabilities and negative equity highlight potential solvency issues. Cash flow improvements are insufficient to mitigate operational losses, indicating a need for strategic changes to achieve financial stability.

Income Statement

The company has seen significant volatility in its revenue over the years with recent improvements. However, profitability remains a concern as indicated by persistent negative net income and EBIT margins. Gross profit has improved recently, but overall profitability metrics are poor, reflecting ongoing financial struggles.

Balance Sheet

The company exhibits a weak balance sheet with negative equity and high liabilities relative to assets. The debt-to-equity ratio is concerning, although recent reductions in debt are positive. The equity ratio is negative, indicating a financially distressed position with potential insolvency risks.

Cash Flow

Cash flow from operations has shown some improvement, but remains negative, indicating ongoing operational challenges. The free cash flow is negative, reflecting inadequate cash generation to cover investments and obligations. The company shows poor cash flow sustainability with high volatility in past years.

Breakdown	TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	630.58K	190.31K	23.95K	63.68K	114.97K	186.15K
Gross Profit	298.48K	181.29K	-146.37K	-209.88K	-24.78K	-281.53K
EBITDA	1.14K	-600.60K	-842.81K	0.00	-215.92K	-845.40K
Net Income	-418.15K	-506.61K	-724.97K	-1.24M	-338.79K	-598.09K
Balance Sheet
Total Assets	150.77K	24.68K	89.29K	441.52K	132.40K	34.74K
Cash, Cash Equivalents and Short-Term Investments	52.34K	4.58K	65.05K	415.73K	99.21K	9.16K
Total Debt	0.00	0.00	0.00	0.00	300.00K	1.30M
Total Liabilities	486.73K	553.85K	505.88K	365.68K	678.88K	2.40M
Stockholders Equity	-335.96K	-529.17K	-416.60K	75.84K	-546.47K	-2.36M
Cash Flow
Free Cash Flow	-290.02K	-60.46K	-350.69K	-195.78K	90.04K	-22.09K
Operating Cash Flow	-290.02K	-60.46K	-350.69K	-195.78K	90.04K	-22.09K
Investing Cash Flow	0.00	0.00	0.00	0.00	0.00	0.00
Financing Cash Flow	340.43K	0.00	0.00	512.30K	0.00	0.00

333D Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CAT	68 Neutral	$1.61B	―	-10.89%	―	17.79%	11.08%
RHT	61 Neutral	AU$18.38M	140.00	-3.11%	―	89.13%	69.57%
RHT	61 Neutral	AU$18.38M	140.00	-3.11%	―	89.13%	69.57%
Sector *	50 Neutral	AU$1.52B	1.82	-28.25%	3.28%	16.21%	-7.40%
AD1	46 Neutral	AU$7.32M	―	-245.01%	―	-17.50%	66.33%
BRN	42 Neutral	$390.79M	―	-133.28%	―	72.47%	20.08%
BRN	42 Neutral	$390.79M	―	-133.28%	―	72.47%	20.08%
T3D	28 Underperform	AU$1.06M	―		―	1110.63%	30.61%

333D Limited Corporate Events

333D Limited Reports Revenue Growth and New Healthcare Contracts

333D Limited reported an increase in cash receipts from customers, totaling $268,339 for the quarter ending March 2025, marking a 1.92% rise from the previous quarter. The company secured two new contracts with healthcare providers, generating over $690,000 in revenue from July to March 2025, reflecting its growing presence in digital asset management and 3D printing services. The net operating cash received was $23,012, and the company incurred expenditures of approximately $245,643, with no material events occurring after the quarter.

333D Limited Appoints John Conidi as CEO to Drive Digital Asset Strategy

333D Limited has appointed Mr. John Conidi as the new CEO and Managing Director, effective March 1, 2025. Mr. Conidi, a substantial shareholder and current director, has been pivotal in advancing the company’s digital asset management strategy, which has led to significant revenue growth in the medical digital asset sector. The company’s focus on R&D to automate processes aligns with the anticipated increase in radiology presentations due to government commitments to Medicare, potentially enhancing operational efficiency and cost-effectiveness for partners.